Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
作者信息
McCurdy Arleigh, Mian Hira, LeBlanc Richard, Jimenez-Zepeda Victor H, Su Jiandong, Masih-Khan Esther, Visram Alissa, Louzada Martha, Song Kevin, White Darrell, Sebag Michael, Stakiw Julie, Reiman Anthony, Aslam Muhammad, Bergstrom Debra, Kotb Rami, Kaedbey Rayan, Gul Engin, Reece Donna, Venner Christopher P
机构信息
Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada.
Juravinski Cancer Center, Hamilton, ON, Canada.
出版信息
Blood Cancer J. 2023 Aug 28;13(1):129. doi: 10.1038/s41408-023-00888-6.
Abstract
摘要
相似文献
1
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.更正：重新定义多发性骨髓瘤（MM）中的损耗：加拿大骨髓瘤研究小组（CMRG）分析。
Blood Cancer J. 2023 Aug 28;13(1):129. doi: 10.1038/s41408-023-00888-6.
2
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.重新定义多发性骨髓瘤（MM）中的流失率：加拿大骨髓瘤研究组（CMRG）的分析。
Blood Cancer J. 2023 Jul 20;13(1):111. doi: 10.1038/s41408-023-00883-x.
3
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.卡非佐米在复发多发性骨髓瘤患者中的使用模式及疗效：来自加拿大骨髓瘤研究组（CMRG）数据库的多机构报告
EJHaem. 2022 Aug 31;3(4):1252-1261. doi: 10.1002/jha2.559. eCollection 2022 Nov.
4
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.达雷妥尤单抗治疗多发性骨髓瘤的疗效：来自加拿大骨髓瘤研究组数据库的回顾性队列研究。
Br J Haematol. 2022 Jul;198(1):93-102. doi: 10.1111/bjh.18172. Epub 2022 Apr 5.
5
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database.卡非佐米和泊马度胺序贯治疗复发多发性骨髓瘤：来自加拿大骨髓瘤研究组（CMRG）数据库的报告。
Curr Oncol. 2022 Mar 2;29(3):1575-1582. doi: 10.3390/curroncol29030132.
6
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database.2007-2018 年按移植状态分层的新诊断多发性骨髓瘤患者的生存和结局：来自加拿大骨髓瘤研究组数据库的回顾性分析。
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):608-617. doi: 10.1016/j.clml.2022.03.002. Epub 2022 Mar 8.
7
Relationship of metabolic and endocrine parameters to brain glucose metabolism in older adults: do cognitively-normal older adults have a particular metabolic phenotype?老年人代谢和内分泌参数与脑葡萄糖代谢的关系：认知功能正常的老年人是否具有特定的代谢表型？
Biogerontology. 2016 Feb;17(1):241-55. doi: 10.1007/s10522-015-9595-7. Epub 2015 Sep 12.
8
The relation between cerebral metabolic rate and ischemic depolarization. A comparison of the effects of hypothermia, pentobarbital, and isoflurane.脑代谢率与缺血性去极化之间的关系。低温、戊巴比妥和异氟烷作用的比较。
Anesthesiology. 1995 May;82(5):1199-208. doi: 10.1097/00000542-199505000-00015.
9
Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment.多发性骨髓瘤中的基因表达谱分析：重新定义风险适应性治疗范式
Front Oncol. 2022 Feb 8;12:820768. doi: 10.3389/fonc.2022.820768. eCollection 2022.
10
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium.骨髓瘤表现与并发症的管理：支持性护理的基石：加拿大骨髓瘤研究小组（原加拿大骨髓瘤研究网络）共识指南联盟的建议
Clin Lymphoma Myeloma Leuk. 2022 Jan;22(1):e41-e56. doi: 10.1016/j.clml.2021.07.028. Epub 2021 Aug 1.
引用本文的文献
1
Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database.复发/难治性多发性骨髓瘤（1-3 线既往治疗）的真实世界治疗模式和结局：Flatiron 数据库。
Blood Adv. 2024 Oct 8;8(19):5062-5071. doi: 10.1182/bloodadvances.2024012640.
Zotero 插件